Voya Investment Management LLC Lowers Stock Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Voya Investment Management LLC cut its holdings in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 29.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 177,695 shares of the medical device company's stock after selling 75,334 shares during the quarter. Voya Investment Management LLC owned about 0.09% of Cooper Companies worth $16,336,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also made changes to their positions in COO. Byrne Asset Management LLC purchased a new stake in Cooper Companies during the 4th quarter valued at approximately $33,000. OFI Invest Asset Management purchased a new stake in shares of Cooper Companies during the fourth quarter worth approximately $34,000. New Age Alpha Advisors LLC acquired a new stake in shares of Cooper Companies during the fourth quarter worth $38,000. Covestor Ltd grew its position in Cooper Companies by 35.5% in the 4th quarter. Covestor Ltd now owns 458 shares of the medical device company's stock valued at $42,000 after buying an additional 120 shares during the last quarter. Finally, West Financial Advisors LLC acquired a new position in Cooper Companies in the 4th quarter valued at $49,000. 24.39% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on COO shares. Piper Sandler restated an "overweight" rating and issued a $115.00 target price (down previously from $120.00) on shares of Cooper Companies in a research note on Friday, March 7th. Needham & Company LLC reaffirmed a "hold" rating on shares of Cooper Companies in a report on Friday, March 7th. Robert W. Baird cut their target price on Cooper Companies from $117.00 to $107.00 and set an "outperform" rating for the company in a research note on Friday, March 7th. Citigroup decreased their price target on Cooper Companies from $115.00 to $110.00 and set a "buy" rating on the stock in a research note on Friday, March 7th. Finally, Stifel Nicolaus cut their price objective on Cooper Companies from $115.00 to $105.00 and set a "buy" rating for the company in a research report on Friday, March 7th. Four analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat.com, Cooper Companies has an average rating of "Moderate Buy" and an average price target of $110.25.

Cooper Companies Price Performance

Cooper Companies stock traded up $1.16 during trading hours on Friday, hitting $82.30. The stock had a trading volume of 1,708,555 shares, compared to its average volume of 1,430,222. The Cooper Companies, Inc. has a 1-year low of $69.81 and a 1-year high of $112.38. The stock has a market capitalization of $16.46 billion, a price-to-earnings ratio of 42.21, a PEG ratio of 2.25 and a beta of 1.01. The stock's fifty day moving average is $81.44 and its two-hundred day moving average is $91.91. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, meeting the consensus estimate of $0.92. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The firm had revenue of $964.70 million during the quarter, compared to the consensus estimate of $981.25 million. As a group, analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.